Aldeyra Therapeutics CEO Todd Brady's 2023 pay jumps 29% to $3.7M
Aldeyra Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 22, 2024
Aldeyra Therapeutics reported fiscal year 2023 executive compensation information on April 22, 2024.
In 2023, three executives at Aldeyra Therapeutics received on average a compensation package of $2.1M, a 9% decrease compared to previous year.
Average pay of disclosed executives at Aldeyra Therapeutics
Todd C. Brady, Chief Executive Officer, received $3.7M in total, which increased by 29% compared to 2022. 44% of Brady's compensation, or $1.6M, was in stock awards. Brady also received $240K in non-equity incentive plan, $1.2M in option awards, $581K in salary, as well as $13K in other compensation.
Stephen G. Machatha, Chief Development Officer, received a compensation package of $1.6M, which decreased by 38% compared to previous year. 68% of the compensation package, or $1.1M, was in option awards.
Bruce Greenberg, Chief Financial Officer, earned $974K in 2023, a 34% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 22, 2024.